At a Glance
| Pentedrone | 2-Aminoindane | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 10–15 mg | 10–20 mg |
| Total Duration | 1.3–2.5 hrs | 0.2–0.5 hrs |
| Routes | insufflatedoral | oral |
Pentedrone, a Stimulants, and 2-Aminoindane, a Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulantss, meaning they share a common pharmacological foundation. They share 22 documented effects in common, with 10 effects unique to Pentedrone and 5 unique to 2-Aminoindane. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Pentedrone | 2-Aminoindane | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 10–15 mg | 10–20 mg |
| Total Duration | 1.3–2.5 hrs | 0.2–0.5 hrs |
| Routes | insufflatedoral | oral |
| Effects | 32 documented | 27 documented |
| Level | Pentedrone | 2-Aminoindane |
|---|---|---|
| Threshold | 2 mg | 3 mg |
| Light | 5–10 mg | 5–10 mg |
| Common | 10–15 mg | 10–20 mg |
| Strong | 15–25 mg | 20–40 mg |
| Heavy | 25 mg | 40 mg |
| Level | Dose |
|---|---|
| Threshold | 1 mg |
| Light | 2–5 mg |
| Common | 5–10 mg |
| Strong | 10–20 mg |
| Heavy | 20 mg |
Pentedrone
2-Aminoindane
No direct interaction data available between these substances. This does not mean the combination is safe.